Next Article in Journal
Biomolecular Aspects of Reelin in Neurodegenerative Disorders: An Old Candidate for a New Linkage of the Gut–Brain–Eye Axis
Previous Article in Journal
Combination Therapy Using Phytochemicals and PARP Inhibitors in Hybrid Nanocarriers: An Optimistic Approach for the Management of Colon Cancer
Previous Article in Special Issue
Candidate Key Proteins of Tinnitus in the Auditory and Motor Systems of the Thalamus
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 26
Issue 15
10.3390/ijms26157351
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Correction to Int. J. Mol. Sci. 2025, 26(7), 3382.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382

by
Wei-Wu Li
1,2,†,
Hsueh-Hui Yang
2,†,
Tzyy-Wen Chiou
3,
Peng-Yeong Woon
4,
Yue-Xuan Xu
1,
Cynthia Tjandra
4,
Ivan Wijaya
4,
Horng-Jyh Harn
5,* and
Shinn-Zong Lin
6,*
1
Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan
2
Department of Medical Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97002, Taiwan
3
Department of Life Science, National Dong Hwa University, Hualien 974301, Taiwan
4
Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 97004, Taiwan
5
Department of Pathology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan
6
Department of Neurology, Hualien Tzu Chi Hospital, Hualien 97002, Taiwan
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Int. J. Mol. Sci. 2025, 26(15), 7351; https://doi.org/10.3390/ijms26157351
Submission received: 16 July 2025 / Accepted: 22 July 2025 / Published: 30 July 2025
(This article belongs to the Special Issue Editorial Board Members’ Collection Series: New Insights into Neuroproteins)
Versions Notes

Missing Funding

In the original publication [1], the funder Gwo Xi Stem Cell Applied Technology Co., Ltd. (grant number: IAC-RD-21-002) was not included. The corrected Funding appears below:
Funding: This research was supported by the National Science and Technology Council, R.O.C (grant number NSTC 113-2314-B-303-005) and Gwo Xi Stem Cell Applied Technology Co., Ltd. (grant number: IAC-RD-21-002).

Conflicts of Interest Correction

The authors would like to modify the Conflict of interest Section of the following published paper [1]. The changes are below.
Conflicts of Interest: The authors declare that this study received funding from Gwo Xi Stem Cell Applied Technology Co., Ltd. (grant number: IAC-RD-21-002). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Li, W.-W.; Yang, H.-H.; Chiou, T.-W.; Woon, P.-Y.; Xu, Y.-X.; Tjandra, C.; Wijaya, I.; Harn, H.-J.; Lin, S.-Z. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, W.-W.; Yang, H.-H.; Chiou, T.-W.; Woon, P.-Y.; Xu, Y.-X.; Tjandra, C.; Wijaya, I.; Harn, H.-J.; Lin, S.-Z. Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382. Int. J. Mol. Sci. 2025, 26, 7351. https://doi.org/10.3390/ijms26157351

AMA Style

Li W-W, Yang H-H, Chiou T-W, Woon P-Y, Xu Y-X, Tjandra C, Wijaya I, Harn H-J, Lin S-Z. Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382. International Journal of Molecular Sciences. 2025; 26(15):7351. https://doi.org/10.3390/ijms26157351

Chicago/Turabian Style

Li, Wei-Wu, Hsueh-Hui Yang, Tzyy-Wen Chiou, Peng-Yeong Woon, Yue-Xuan Xu, Cynthia Tjandra, Ivan Wijaya, Horng-Jyh Harn, and Shinn-Zong Lin. 2025. "Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382" International Journal of Molecular Sciences 26, no. 15: 7351. https://doi.org/10.3390/ijms26157351

APA Style

Li, W.-W., Yang, H.-H., Chiou, T.-W., Woon, P.-Y., Xu, Y.-X., Tjandra, C., Wijaya, I., Harn, H.-J., & Lin, S.-Z. (2025). Correction: Li et al. The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease. Int. J. Mol. Sci. 2025, 26, 3382. International Journal of Molecular Sciences, 26(15), 7351. https://doi.org/10.3390/ijms26157351

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop